Phase Ib Study of Regorafenib (REG) Plus Pembrolizumab (PEMBRO) for First-Line Treatment of Advanced Hepatocellular Carcinoma (HCC)
Keck Medicine of USC
Keck Medicine of USC has launched the USC Nursing Institute to promote education, leadership development, clinical expertise and research among nurses.
Keck Medicine of USC hospitals and USC Student Health, part of Keck Medicine, received the ‘LGBTQ+ Healthcare Equality Leader’ designation in the Human Rights Campaign Foundation’s 2024 Healthcare Equality Index (HEI).
Keck Hospital of USC earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national watchdog organization.
Keck Medicine of USC has opened a new location in Las Vegas that will provide specialized care for patients in Las Vegas and surrounding communities who need a liver or heart transplant.
A clinical trial from Keck Medicine of USC will test the feasibility of treating non-small cell lung cancer with immunotherapy provided at home.
A clinical trial from Keck Medicine of USC aims to provide a surgical solution for patients with a form of advanced pancreatic cancer previously considered inoperable.
A new study from Keck Medicine of USC shows that adults with hearing loss who regularly used hearing aids had a 24% lower risk of mortality than those who never wore them.
The Leapfrog Group, a national hospital watchdog organization, has named USC Norris Cancer Hospital a 2023 Top Teaching Hospital.
Approximately 7% of Americans have had long COVID, a range of ongoing health problems experienced after infection and recovery from COVID-19. Symptoms can include fatigue, brain fog, headaches, chest pain, heart palpitations and more.
Keck Medicine of USC has named Chris Allen chief financial officer (CFO), effective Aug. 31.
Keck Medicine of USC experts discuss new recommendations for staying healthy and safe during the respiratory virus season
Keck Hospital of USC earns five stars from the Centers for Medicare & Medicaid Services (CMS) annual quality star rating report
A new study from Keck Medicine of USC has uncovered significant racial disparities in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the United States.
Paul B. Rothman, MD, has been appointed as a member of the USC Health System Board, which provides strategic oversight and governance over Keck Medicine of USC and university clinical services.
A new study from Keck Medicine of USC published in the Annals of Internal Medicine shows that heavy alcohol use may be dramatically more damaging to the liver for people with metabolic syndrome.
For the first time, USC Verdugo Hills Hospital (USC-VHH) earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national watchdog organization, for achieving the highest national standards in patient safety. This achievement places USC-VHH among top tier hospitals in the nation for safety and quality.
A newly published study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation.